STERLING STY SEEKS FDA APPROVAL FOR MILRINONE NEW YORK March Sterling Drug Inc said it submitted a new drug application to the Food and Drug Administration for permission to market an oral form of Corotrope milrinone a drug for treating chronic congestive heart failure Sterling said the application includes a series of studies of patients and results of three multicenter studies involving another patients to demonstrate the efficacy and safety of the drug as an alternative to digitalis Reuter